FREE Account Opening + No Clearing Fees
Loading...

Ambey Laboratories IPO vs Nephro Care India IPO

Comparision between Ambey Laboratories IPO and Nephro Care India IPO.

IPO Details

Ambey Laboratories IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Nephro Care India IPO is a SME Book Built Issue proposed to list at NSE SME.

  Ambey Laboratories IPO Nephro Care India IPO
Logo Ambey Laboratories IPO Logo Nephro Care India IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Book Built Issue Book Built Issue
Listing At NSE SME NSE SME
Lead Managers Fast Track Finsec Pvt Ltd Corporate Capitalventures Pvt Ltd
Registrar Link Intime India Private Ltd Bigshare Services Pvt Ltd
Market Maker Nikunj Stock Brokers Limited Ss Corporate Securities Limited
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor Anchor Investor Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Ambey Laboratories IPO is up to ₹44.68 Cr whereas the issue size of the Nephro Care India IPO is up to ₹41.26 Cr. The final issue price of Ambey Laboratories IPO is ₹68.00 per share and of Nephro Care India IPO is ₹90.00 per share.

  Ambey Laboratories IPO Nephro Care India IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹65.00 per share ₹85.00 per share
Issue Price (Upper) ₹68.00 per share ₹90.00 per share
Issue Price (Final) ₹68.00 per share ₹90.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 2000 shares 1600 shares
Fresh Issue Size 62,58,000 shares 45,84,000 shares
Fresh Issue Size (Amount) up to ₹42.55 Cr up to ₹41.26 Cr
OFS Issue Size 3,12,000 shares
OFS Issue Size (Amount) up to ₹2.12 Cr
Issue Size Total 65,70,000 shares 45,84,000 shares
Issue Size Total (Amount) up to ₹44.68 Cr up to ₹41.26 Cr

IPO Timetable

Ambey Laboratories IPO opens on Jul 04, 2024, while Nephro Care India IPO opens on Jun 28, 2024. The closing date of Ambey Laboratories IPO and Nephro Care India IPO is Jul 08, 2024, and Jul 02, 2024, respectively.

  Ambey Laboratories IPO Nephro Care India IPO
Anchor Bid Date Jul 03, 2024 Jun 27, 2024
Issue Open Jul 04, 2024 Jun 28, 2024
Issue Close Jul 08, 2024 Jul 02, 2024
Basis Of Allotment (Tentative) Jul 09, 2024 Jul 03, 2024
Initiation of Refunds (Tentative) Jul 10, 2024 Jul 04, 2024
Credit of Share (Tentative) Jul 10, 2024 Jul 04, 2024
Listing date (Tentative) Jul 11, 2024 Jul 05, 2024
Anchor Lockin End date 1 Aug 08, 2024 Aug 02, 2024
Anchor Lockin End date 2 Oct 07, 2024 Oct 01, 2024

Financials

Ambey Laboratories IPO P/E ratio is 27.81, as compared to Nephro Care India IPO P/E ratio of 55.15.

  Ambey Laboratories IPO Nephro Care India IPO
Financial

Ambey Laboratories Limited Financial Information (Restated)

Period Ended31 Jan 202431 Mar 202331 Mar 202231 Mar 2021
Assets8,620.845,761.855,592.944,461.80
Revenue10,043.6910,743.478,511.198,241.54
Profit After Tax607.73456.93357.471,033.67
Net Worth3,431.342,363.601,906.67-786.39
Reserves and Surplus1,562.46588.66131.73-1,275.74
Total Borrowing2,005.441,365.221,804.863,292.98
Amount in ₹ Lakhs

Nephro Care India Limited Financial Information (Restated)

Nephro Care India Limited's revenue increased by 398.84% and profit after tax (PAT) rose by 19920.41% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended31 Dec 202331 Mar 202331 Mar 202231 Mar 2021
Assets2,029.85831.11462.93112.84
Revenue1,989.601,709.51342.70183.26
Profit After Tax340.04194.24-0.988.87
Net Worth1,392.32243.7649.521.50
Reserves and Surplus1,332.81193.76-0.480.50
Total Borrowing246.39253.7469.27
Amount in ₹ Lakhs
Promoter Shareholding (Pre-Issue) 94.97% 85.02%
Promoter Shareholding (Post-Issue) 69.90% 61.39%
P/E Ratio 27.81 55.15
Market Cap ₹171.64 Cr. ₹148.38 Cr.
ROE 20.80%% 41.57%%
ROCE 13.14%% 36.56%%
Debt/Equity 0.58
EPS ₹2.44 ₹1.63
RoNW 20.80%% 24.42%%

Shares Offered

In the Ambey Laboratories IPO retail investors (RII) are offered 21,84,000 shares while in Nephro Care India IPO retail investors are offered 21,84,000 shares. Qualified institutional buyers (QIB) are offered 12,52,000 shares in Ambey Laboratories IPO and 8,25,600 shares in Nephro Care India IPO.

  Ambey Laboratories IPO Nephro Care India IPO
Anchor Investor Reserveration 18,72,000 shares 12,38,400 shares
Market Maker Reserveration 3,30,000 shares 2,30,400 shares
QIB 12,52,000 shares 8,25,600 shares
NII 6,06,001 shares 6,19,200 shares
RII 21,84,000 shares 14,44,800 shares
Employee 0 shares 0 shares
Others
Total 40,42,001 shares 31,15,200 shares

Bids Received (Subscription)

Ambey Laboratories IPO subscribed 173.18x in total, whereas Nephro Care India IPO subscribed 715.78x.

  Ambey Laboratories IPO Nephro Care India IPO
QIB (times) 61.90x 245.14x
NII (times) 324.22x 1,787.19x
Big NII (times)
Small NII (times)
RII (times) 195.06x 634.12x
Employee (times)
Other (times)
Total (times) 173.18x 715.78x

Comments

Add a public comment...